PDF
ePub
Citation
Print
Su-Mi Choi, MD1
, Dong-Gun Lee, MD1, 2
, Dong-Gun Lee, MD1, 2
Abstract
The inappropriate use of antimicrobial agents results in collateral damages such as treatment failure, an increased frequency of adverse events related to antimicrobial agents, the emergence of resistant bacteria, and increased medical costs. The selection of appropriate antimicrobial agents begins with taking a detailed history and performing a thorough physical examination to determine whether the cause of the fever is infectious or non-infectious. Based on the patient's symptoms and signs, the site of infection (a system-oriented approach) and the causative organism with high possibility (a pathogenesis-oriented approach: intracellular vs. extracellular) can be estimated. In this process, host factors, microbial factors, and the characteristics of antimicrobial agents should be considered. Herein, we summarize the recently developed Korean guidelines for the use of antimicrobial agents for infectious diseases. We also introduce the antimicrobial website and application developed by Korean Society for Antimicrobial Therapy and the antimicrobial stewardship program.
Figures and Tables
Figure 1
Approaches to febrile patients (A) and general considerations in selecting appropriate antimicrobial agents (B). G (+), gram-positive organisms; G (−), gram-negative organisms; PK/PD, pharmacokinetics/pharmacodynamics; TDM, therapeutic drug monitoring.
Table 1
Organ/system-oriented approach for infectious diseases and its suggestive symptoms and signs
Table 3
Core elements of hospital antibiotic stewardship program
Adapted from Pollack LA, et al. Clin Infect Dis 2014;59 Suppl 3:S97-S100 [28].
References
1. Pillai SK, Eliopoulos GM, Moellering RC. Principles of anti-infective therapy. In : Mandell GL, Douglas RG, Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia: Churchill Livingstone Elsevier;2015. p. 224–234.
2. Oh MD, Choe KW. General principles of antibiotics use. The Korean Society of Infectious Diseases. Textbook of guidepost to antimicrobial. 4th ed. Seoul: Koonja;2016. p. 53–66.
3. Yoo JH. The Infinity war: how to cope with carbapenem-resistant Enterobacteriaceae. J Korean Med Sci. 2018; 33:e255.
4. Surana NK, Kasper DL. Approach to the patient with an infectious disease. In : Jameson JL, editor. Harrison's principles of internal medicine. New York: McGraw Hill;2018. p. 859–866.
5. Barlam TF, Kasper DL. Approach to the acutely ill infected febrile patient. In : Jameson JL, editor. Harrison's principles of internal medicine. New York: McGraw Hill;2018. p. 877–884.
6. Hessen MT, Kaye D. Principles of use of antibacterial agents. Infect Dis Clin North Am. 2004; 18:435–450.
7. Tunkel AR, van de Beek D, Scheld WM. Acute meningitis. In : Mandell GL, Douglas RG, Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia: Churchill Livingstone Elsevier;2015. p. 1097–1137.
8. Kang CI. Principles of antimicrobial therapy in elderly patients. Korean J Med. 2010; 79:362–365.
9. Hessen MT, Kaye D. Principles of selection and use of anti-bacterial agents. In vitro activity and pharmacology. Infect Dis Clin North Am. 2000; 14:265–279.
10. Kim SW. Therapeutic drug monitoring (TDM) of antimicrobial agents. Infect Chemother. 2008; 40:133–139.
11. Yoon YK, Park CS, Kim JW, Hwang K, Lee SY, Kim TH, Park DY, Kim HJ, Kim DY, Lee HJ, Shin HY, You YK, Park DA, Kim SW. Guidelines for the antibiotic use in adults with acute upper respiratory tract infections. Infect Chemother. 2017; 49:326–352.
12. Lee MS, Oh JY, Kang CI, Kim ES, Park S, Rhee CK, Jung JY, Jo KW, Heo EY, Park DA, Suh GY, Kiem S. Guideline for antibiotic use in adults with community-acquired pneumonia. Infect Chemother. 2018; 50:160–198.
13. Kang CI, Kim J, Park DW, Kim BN, Ha US, Lee SJ, Yeo JK, Min SK, Lee H, Wie SH. Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infect Chemother. 2018; 50:67–100.
14. Kwak YG, Choi SH, Kim T, Park SY, Seo SH, Kim MB, Choi SH. Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Infect Chemother. 2017; 49:301–325.
15. Korean Society of Infectious Diseases. Korean Society for Chemotherapy. Korean Society of Clinical Microbiology. Clinical guideline for the diagnosis and treatment of gastrointestinal infections. Infect Chemother. 2010; 42:323–361.
16. Korean Society of Infectious Diseases. Korean Society for Chemotherapy. Korean Society of Clinical Microbiology. Korean Society of Cardiology. Korean Society for Thoracic and Cardiovascular Surgery. Clinical guideline for the diagnosis and treatment of cardiovascular infections. Infect Chemother. 2011; 43:129–177.
17. Lee DG, Kim SH, Kim SY, Kim CJ, Min CK, Park WB, Park YJ, Song YG, Jang JS, Jang JH, Jin JY, Choi JH. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Infect Chemother. 2011; 43:285–321.
18. Korean Society of Infectious Diseases. Korean Society for Chemotherapy. Korean Neurological Association. Korean Neurosurgical Society. Korean Society of Clinical Microbiology. Clinical practice guidelines for the management of bacterial meningitis in adults in Korea. Infect Chemother. 2012; 44:140–163.
19. Choi WS, Lee J, Lee HY, Baek JH, Kim YK, Kee SY, Jeong HW, Kim YK, Song JY, Wie SH, Lee JS. Transgovernmental Enterprise for Pandemic Influenza in Korea. Clinical practice guideline for antiviral treatment and chemoprophylaxis of seasonal influenza. Infect Chemother. 2012; 44:233–249.
20. Choi WS, Baek JH, Seo YB, Kee SY, Jeong HW, Lee HY, Eun BW, Choo EJ, Lee J, Kim YK, Song JY, Wie SH, Lee JS, Cheong HJ, Kim WJ. Transgovernmental Enterprise for Pandemic Influenza in Korea. Severe influenza treatment guideline. Korean J Med. 2014; 86:116–128.
21. Korean Society for AIDS. Clinical guidelines for the diagnosis and treatment of HIV/AIDS in HIV-infected Koreans. Infect Chemother. 2011; 43:89–128.
22. Korean Society for AIDS. Clinical guidelines for the treatment and prevention of opportunistic infections in HIV-infected Koreans. Infect Chemother. 2012; 44:93–139.
23. Korean Society for AIDS. The 2013 clinical guidelines for the diagnosis and treatment of HIV/AIDS in HIV-infected Koreans. Infect Chemother. 2013; 45:455–461.
24. Korean Society for AIDS. The 2015 clinical guidelines for the diagnosis and treatment of HIV/AIDS in HIV-infected Koreans. Infect Chemother. 2015; 47:205–211.
25. Korean Society for AIDS. The 2018 clinical guidelines for the diagnosis and treatment of HIV/AIDS in HIV-infected Koreans. Infect Chemother. 2019; 51:77–88.
26. Chong YP, Song JY, Seo YB, Choi JP, Shin HS. Rapid Response Team. Antiviral treatment guidelines for Middle East respiratory syndrome. Infect Chemother. 2015; 47:212–222.
27. Korean Centers for Diseases Control and Prevention. Korean Association of Urogenital Tract Infection and Inflammation. 2016 Korean guidelines for sexually transmitted infections [Internet]. Cheongju: Korean Centers for Diseases Control and Prevention;2017. cited 2019 Apr 7. Available from: http://www.cdc.go.kr/CDC/together/CdcKrTogether0302.jsp?menuIds=HOME006-MNU2804-MNU3027-MNU2979&cid=138110.
28. Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014; 59:Suppl 3. S97–S100.
29. Kim HI, Kim SW, Chang HH, Kim HB. A survey of antimicrobial stewardship programs in Korean hospitals. Korean J Med. 2014; 87:173–181.
30. Kim B, Kim J, Kim SW, Pai H. A survey of antimicrobial stewardship programs in Korea, 2015. J Korean Med Sci. 2016; 31:1553–1559.
31. Song YJ, Kim M, Huh S, Lee J, Lee E, Song KH, Kim ES, Kim HB. Impact of an antimicrobial stewardship program on unnecessary double anaerobic coverage prescription. Infect Chemother. 2015; 47:111–116.
32. Park SM, Kim HS, Jeong YM, Lee JH, Lee E, Lee E, Song KH, Kim HB, Kim ES. Impact of intervention by an antimicrobial stewardship team on conversion from intravenous to oral fluoroquinolones. Infect Chemother. 2017; 49:31–37.
XML Download